Tariq Fahmi

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

NCTR primary UAMS

Also affiliated: United States Food and Drug Administration (2017–2026); University of Arkansas Medical Center (2014); Central Arkansas Veterans Healthcare System (2015)

10 h-index 22 pubs 621 cited

Research Areas

Biomedical Subjects

Links

Lab Website

OverviewAI-generated summary

Tariq Fahmi's research focuses on the mechanisms of cytotoxicity and nanoparticle-based drug delivery, particularly in the context of cancer and neurological disorders. He has investigated the role of endonucleases in graphene-induced cytotoxicity and the protective effects of the serotonin transporter against apoptosis in placental cells. His work also includes studies on functionalized silver-gold nanorods for circulating tumor cell identification and the use of single-walled carbon nanotubes and graphene for nanodelivery of chemotherapeutic agents to cancer cells. Fahmi has also explored the impact of hydroxychloroquine on atherosclerosis and vascular stiffness in patients with chronic kidney disease. His research collaborations include work with Anil K. Patri, Sanghamitra Majumdar, Kevin L. Trout, and Paul Rogers at the National Center for Toxicological Research.

Metrics

h-index: 10
Publications: 22
Citations: 621

Selected Publications

Evaluation of sources of variability in a nitric oxide screening assay for engineered nanomaterials (2025)

Nanomedicine Nanotechnology Biology and Medicine DOI OpenAlex
Investigation of sex-based differences in the immunotoxicity of silver nanoparticles (2024)

Nanotoxicology 10 citations DOI OpenAlex
Radiation impacts on toxicity of cobalt–chromium (CoCr) implant debris (2023)

Nanotoxicology 1 citation DOI OpenAlex
Development of benchmark datasets for text mining and sentiment analysis to accelerate regulatory literature review (2022)

Regulatory Toxicology and Pharmacology 5 citations DOI OpenAlex
DNase I Induces Other Endonucleases in Kidney Tubular Epithelial Cells by Its DNA-Degrading Activity (2020)

International Journal of Molecular Sciences 10 citations DOI OpenAlex
Mechanism of graphene‐induced cytotoxicity: Role of endonucleases (2017)

Journal of Applied Toxicology 33 citations DOI OpenAlex
Photoacoustic flow cytometry for nanomaterial research (2017)

Photoacoustics 25 citations DOI OpenAlex
Serotonin transporter protects the placental cells against apoptosis in caspase 3‐independent pathway (2017)

Journal of Cellular Physiology 55 citations DOI OpenAlex
584. Improvement of Gene Delivery By Inhibition of Endonucleases (2015)

Molecular Therapy DOI OpenAlex
Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease (2015)

PLoS ONE 33 citations DOI OpenAlex
Regulation of Apoptotic Endonucleases by EndoG (2015)

DNA and Cell Biology 64 citations DOI OpenAlex
Circulating tumor cell identification by functionalized silver-gold nanorods with multicolor, super-enhanced SERS and photothermal resonances (2014)

Scientific Reports 200 citations DOI OpenAlex
Novel High-Throughput Deoxyribonuclease 1 Assay (2014)

SLAS DISCOVERY 9 citations DOI OpenAlex
Single‐walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells (2014)

Journal of Applied Toxicology 54 citations DOI OpenAlex
Alternatively‐spliced DNase I acts as dominant‐negative inhibiting cisplatin toxicity to kidney cells (2013)

The FASEB Journal DOI OpenAlex